IMM 3.13% 31.0¢ immutep limited

Immutep has been featured in the latest Thematic Insights Report - Download now!

  1. 7,809 Posts.
    lightbulb Created with Sketch. 1152
    In the latest Thematic Insights report, we look at what companies must do under the Australian drug regulator to bring a new product to market.

    CLICK TO DOWNLOAD REPORT
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.